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Introduction {#s1}
============

Chronic bronchitis is a common clinical condition defined by chronic cough and sputum production for at least 3 mo in 2 or more consecutive years ([@c7]). Prevalence estimates in the general population of adults range from 3.5 to 27% ([@c16]; [@c19]; [@c21]). This wide range may reflect, in part, variability in case definitions. Chronic bronchitis is a phenotype of chronic obstructive pulmonary disease (COPD) ([@c15]). Among persons with COPD, chronic bronchitis portends increased frequency and severity of exacerbations ([@c4]; [@c16]). Among persons without COPD, chronic bronchitis symptoms predict an increased risk of developing COPD, lower health-related quality-of-life scores, and increased risk for all-cause mortality ([@c9]; [@c11]; [@c17]; [@c19]).

Smoking is the primary risk factor for chronic bronchitis, but exposure to ambient air pollution may also contribute ([@c15]). The relationship between short-term air pollution exposure and acute respiratory symptoms and hospitalizations is well established ([@c23]; [@c24]; [@c31]), but limited data suggest a relationship between long-term ambient pollution exposure and COPD ([@c26]). There is a paucity of data on the possible relationship between classically defined chronic bronchitis and long-term exposure to the criteria pollutants ${PM}_{2.5}$, ${PM}_{10}$ (particulate matter $< 2.5\,\mu m$ and $< 10\,\mu m$ in diameter, respectively), and nitrogen dioxide $\left( \text{NO}_{2} \right)$. The sparse existing data provide inconsistent support for an association between ${PM}_{10}$ and chronic cough and phlegm, and between $\text{NO}_{2}$ and chronic cough ([@c3]; [@c5]; [@c27]; [@c34]).

To address these relationships in a larger study, using specific outcome definitions and advanced exposure assessments, we investigated the association between residential exposure to ${PM}_{2.5}$, ${PM}_{10}$, and $\text{NO}_{2}$ and both incident and prevalent chronic bronchitis in a prospective nationwide cohort of more than 50,000 U.S. women participating in the National Institute of Environmental Health Sciences (NIEHS) Sister Study. We estimated exposure at individuals' residential addresses. Taking advantage of the comprehensive survey, we uniformly classified cases of chronic bronchitis using the classical clinical definition.

Methods {#s2}
=======

Study Population {#s2.1}
----------------

The NIEHS Sister Study is a longitudinal cohort study of U.S. women with a sister diagnosed with breast cancer, but no personal breast cancer diagnosis at time of baseline interview ($n = 50,884$). Women were enrolled between August 2003 and March 2009, and completed a baseline computer-assisted telephone survey. Follow-up telephone surveys were performed every 2 to 3 y. We analyzed data through the second follow-up survey (data release 4, data available through August 2014). Baseline and follow-up surveys queried participants on a wide range of health diagnoses and symptoms.

Of the 50,884 women participating in the NIEHS Sister Study, 1,234 (2.4%) were excluded for missing exposure data due to residential locations outside the modeling region or addresses that could not be geocoded ([Figure 1](#f1){ref-type="fig"}). After excluding those missing baseline data on cough and phlegm, 47,357 individuals remained for analysis of prevalent outcomes. Of the 45,955 participants without chronic bronchitis symptoms at baseline, 6,111 (12.3%) were missing data on cough or phlegm for at least one of the two follow-up questionnaires, leaving 39,844 individuals for analysis of incident outcomes.

![Study population with excluded/missing participants.\
\*Total number of participants with nonmissing covariates for prevalence analyses is 44,158.\
†Total number of participants with nonmissing covariates for incidence analysis is 38,006.](EHP2199_f1){#f1}

The Institutional Review Boards of the University of Washington and the NIEHS approved this study; all participants provided written informed consent.

Outcome Assessment {#s2.2}
------------------

Chronic bronchitis was defined according to the classical symptom-based definition of chronic cough productive of phlegm for at least 3 mo out of a year for a minimum of 2 consecutive years ([@c7]). Participants were asked about the presence of cough and phlegm independently, and the duration of each symptom was specified using questions derived from the British Medical Research Council adult respiratory symptom standardized questionnaire. Women with cough and phlegm symptoms, both present for at least 3 mo per year out of the previous 2 y, were considered to have chronic bronchitis. Prevalent chronic bronchitis was determined by meeting symptom-based criteria at the baseline questionnaire. In a sensitivity analysis, we included history of physician diagnosis of chronic bronchitis in the case definition. Incident chronic bronchitis was defined by satisfying the case definition at either the second follow-up survey, or both the first and second follow-ups among participants who did not have chronic bronchitis at baseline. Participants whose symptoms did not persist from first through second follow-up were not considered cases.

Secondary outcomes were chronic cough (3 or more months of cough for at least 2 consecutive years, regardless of phlegm production), chronic phlegm (3 or more months of phlegm production for at least 2 consecutive years, regardless of cough), and chronic cough or phlegm. Both prevalent chronic cough and chronic phlegm were defined by being present at baseline.

Ambient Air Pollution Exposure Assessment {#s2.3}
-----------------------------------------

Air pollution exposure was estimated using annual average ${PM}_{2.5}$, ${PM}_{10}$, and $\text{NO}_{2}$ levels at each participant's current primary residence. Home addresses of participants were geocoded using ArcGIS (version 10; Esri). We estimated long-term exposure using year 2000 annual mean concentration levels for all pollutants. Measurements of ${PM}_{2.5}$, ${PM}_{10}$, and $\text{NO}_{2}$ concentrations from monitors using federal reference methods were obtained from the U.S. Environmental Protection Agency (EPA) Air Quality System database. After excluding locations with only seasonal coverage or large amounts of missing data, the observations were aggregated into annual averages. The annual averages were used to fit a universal kriging regression model for predicting at points within the contiguous United States. The models for ${PM}_{2.5}$ ([@c25]) and $\text{NO}_{2}$ ([@c33]) have been previously described in detail, and the model for ${PM}_{10}$ was fit in the same manner as the ${PM}_{2.5}$ model. Partial least squares, a dimension reduction technique, was used to select linear combinations of land use, roadway proximity, and other geographic covariates. The $\text{NO}_{2}$ prediction model additionally incorporated satellite data ([@c33]). Spatial smoothing was included via an exponential covariance function. This model therefore incorporated land-use regression and spatial smoothing of values observed in the monitoring network. Model performance was evaluated using 10-fold cross-validation and for the year 2000. The cross-validated $R^{2}$ was 0.85 for $\text{NO}_{2}$, 0.53 for ${PM}_{10}$, and 0.77 for ${PM}_{2.5}$. Exposure modeling was limited to the continental United States; participants from Alaska, Hawaii, and Puerto Rico were excluded ($n = 1,234$).

Statistical Analysis {#s2.4}
--------------------

To estimate the association between outcomes and pollutant exposures, we used multivariable logistic regression. Covariates were selected *a priori* based on plausible relationships and review of existing literature. Potential confounders, measured at baseline, were age (continuous), ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, other), body mass index (continuous), education (high school or less, some college, associate or technical degree, bachelor's degree, graduate degree), household income (continuous), occupational exposure to dust (ever/never) or vapors/fumes (ever/never), smoking status (never, former, current), tobacco pack-years (continuous), and years of secondhand smoke exposure since age 19 (continuous). After exclusion of individuals missing any of these covariates, 44,158 individuals were available for the analysis of prevalent outcomes. For incident outcomes, among those without chronic bronchitis at baseline, 38,006 individuals were available after excluding missing covariates.

A model adjusted for age alone was first performed followed by a fully adjusted model including all *a priori* identified covariates. ${PM}_{2.5}$, ${PM}_{10}$, and $\text{NO}_{2}$ were modeled separately. Given potential bias by length of follow-up time for the incident chronic bronchitis outcome, adjustment was made for duration of follow-up time (from baseline to second follow-up survey) using restricted cubic splines with four knots ([@c10]). We performed analyses stratified by baseline smoking status (ever/never) and tested for interaction using product terms for smoking status and pollutant exposure. A two-pollutant model was performed by including remaining copollutants in the fully adjusted model. In all instances, a *p*-value of $< 0.05$ was considered significant.

Sensitivity analyses were prespecified and performed on the following subgroups in independent analyses: *a*) prevalent chronic bronchitis that included either symptom-based criteria or report of physician diagnosis; *b*) excluding baseline asthmatics \[defined by history of physician diagnosis, recent (within 12 mo) asthma medication use, and self-reported current asthma\], given clinical overlap between asthma and chronic bronchitis; and *c*) participants who lived at least 10 y at their primary residence. In the asthma sensitivity analysis, asthmatics who reported either current smoking or history of $\geq 10$ pack-years at baseline were not excluded given possibility of smoking-related symptoms leading to asthma misdiagnosis. Given concern that seasonal variation may affect results, an additional sensitivity analysis was performed by adjusting for season at the time of baseline and follow-up questionnaires.

Statistical analysis was performed using the statistical program Stata (version 11; StataCorp).

Results {#s3}
=======

Participants were, on average, 55.4 y old at baseline $\left\lbrack \text{standard}\,\text{deviation}\,\left( \text{SD} \right) = 8.9 \right\rbrack$, 84.8% were white, 52.6% had a bachelor's degree or higher level of education, 56.4% had never smoked cigarettes, and only 8% were current smokers. The proportion of black and Hispanic participants increased across tertiles of ${PM}_{2.5}$, ${PM}_{10}$, and $\text{NO}_{2}$ ([Table 1](#t1){ref-type="table"}). The distributions of occupational exposures, smoking history, and cumulative tobacco smoke exposure did not vary materially by ambient air pollution exposure levels ([Table 1](#t1){ref-type="table"}).

###### 

Participant characteristics at baseline by exposure tertiles for particulate matter ${PM}_{2.5}$, ${PM}_{10}$, and $\text{NO}_{2}$.

Table 1 lists characteristics in the first column; the corresponding values of exposure tertiles for PM sub 2.5 in micrograms per cubic meter, N O sub 2 in parts per billion, and PM sub 10 in micrograms per cubic meter are listed in the other columns.

  Characteristic                                   ${PM}_{2.5}$ (${\mu g/m}^{3}$)   $\text{NO}_{2}$ (ppb)   ${PM}_{10}$ (${\mu g/m}^{3}$)                                                                                                                
  ----------------------------------------------- -------------------------------- ----------------------- ------------------------------- --------------------- --------------------- --------------------- --------------------- --------------------- ---------------------
  $n$                                                          14,720                      14,719                      14,719                     14,720                14,719                14,719                14,720                14,719                14,719
  Age (years)                                              $55.9 \pm 8.9$               $55.4 \pm 9$               $54.9 \pm 8.9$             $55.7 \pm 8.8$        $55.3 \pm 8.9$         $55.3 \pm 9$         $55.7 \pm 8.7$        $55.3 \pm 8.9$         $55.3 \pm 9$
  BMI                                                       $27.5 \pm 6$               $27.9 \pm 6.3$              $28.3 \pm 6.5$             $27.8 \pm 6.1$        $27.8 \pm 6.3$        $27.9 \pm 6.5$        $27.5 \pm 6.1$        $27.9 \pm 6.3$        $28.2 \pm 6.5$
  Race/ethnicity (%)                                                                                                                                                                                                                                                
   White (non-Hispanic)                                         90.7                        85.9                        77.7                       89.2                  85.4                  79.7                  90.1                  85.5                  78.6
   Black (non-Hispanic)                                         2.4                          8.7                        16.8                        5.6                   9.4                  12.9                   5.6                   9.4                  12.9
   Hispanic                                                     4.1                          2.9                          3                         2.3                   2.9                   4.8                   1.8                   2.7                   5.6
   Other                                                        2.8                          2.5                         2.5                        2.9                   2.3                   2.6                   2.5                   2.3                    3
  Education (%)                                                                                                                                                                                                                                                     
   HS or less                                                   14.7                        15.1                        14.8                       17.6                  14.8                  12.3                  15.1                  15.1                  14.5
   Some college                                                 35.2                        33.5                        32.1                       36.8                  33.3                  30.8                  33.7                  32.7                  34.3
   Bachelor's                                                   27.4                         27                         26.9                       25.7                  27.4                  28.2                  26.6                  27.3                  27.4
   Graduate                                                     22.8                        24.4                        26.2                        20                   24.6                  28.8                  24.6                   25                   23.8
  Household income (USD)                                $41,218 \pm 25,849$          $43,570 \pm 26,914$         $43,743 \pm 28,293$        $39,995 \pm 24,817$   $43,064 \pm 26,339$   $45,472 \pm 29,533$   $42,473 \pm 25,999$   $43,104 \pm 26,892$   $42,953 \pm 28,242$
  Occupational Exposures (%)                                                                                                                                                                                                                                        
   Vapors/fumes (ever)                                          24.9                        24.3                         24                        25.7                  24.1                  23.5                  24.4                  24.4                  24.4
   Dust (ever)                                                  22.2                        22.7                        23.8                       23.5                  22.4                  22.9                  22.7                  22.6                  23.5
  Smoking status (%)                                                                                                                                                                                                                                                
   Never                                                        56.2                        55.7                        57.2                       57.2                  57.3                  54.6                  54.4                  57.4                  57.3
   Former                                                       36.6                        36.4                        33.9                       34.8                   35                   37.1                  37.6                  34.8                  34.5
   Current                                                      7.2                           8                          8.9                        8.1                   7.7                   8.3                   7.9                   7.8                   8.3
  Pack-years among ever-smokers                           $14.5 \pm 15.3$              $14.7 \pm 15.2$             $14.8 \pm 15.5$            $15.1 \pm 15.6$       $14.3 \pm 15.1$       $14.5 \pm 15.2$       $14.8 \pm 15.5$       $14.5 \pm 15.2$       $14.6 \pm 15.2$
  Packs per day among current smokers                      $0.7 \pm 0.4$                $0.7 \pm 0.4$               $0.7 \pm 0.5$              $0.7 \pm 0.5$         $0.7 \pm 0.4$         $0.6 \pm 0.4$         $0.7 \pm 0.5$         $0.7 \pm 0.4$         $0.7 \pm 0.4$
  Adult secondhand smoke (years)                          $10.9 \pm 12.9$              $11.3 \pm 13.3$             $11.4 \pm 13.2$            $11.5 \pm 13.2$       $11.1 \pm 13.1$       $11.1 \pm 13.1$       $11.3 \pm 13.1$       $11.1 \pm 13.1$       $11.3 \pm 13.3$
  Number of years at primary residence                    $12.8 \pm 10.9$              $13.5 \pm 11.3$             $13.6 \pm 11.5$             $12.7 \pm 11$        $12.7 \pm 10.7$       $14.6 \pm 11.8$        $13.4 \pm 11$        $13.2 \pm 11.2$       $13.3 \pm 11.5$
  Lived at primary residence $\geq 10\; y$ (%)                  50.7                        53.5                        53.9                       50.1                  50.8                  57.1                  53.6                  52.2                  52.4
  Asthma at baseline (%)                                        5.7                          5.6                         5.9                         5                     6                    6.3                   5.4                   5.9                    6
  Physician diagnosis of COPD (%)                               1.5                          1.5                         1.5                        1.6                   1.6                   1.4                   1.5                   1.5                   1.5
  Physician diagnosis of chronic bronchitis (%)                 7.4                           8                          8.4                         8                    8.1                   7.8                   7.5                    8                    8.4

Note: BMI, body mass index; COPD, chronic obstructive pulmonary disease; HS, high school; PM, particulate matter.

The mean follow-up time was 5.7 y from enrollment to the second follow-up survey. During the follow-up period, there were 638 incident cases of chronic bronchitis, giving an estimated incidence rate of 2.8 cases per 1,000 person-years. At baseline, 1,351 (3.1%) women met symptom-based criteria for chronic bronchitis, whereas 4,698 (10.6%) participants reported ever having had a physician diagnosis of chronic bronchitis. Prevalent chronic cough was reported by 3,749 (8.5%) and chronic phlegm by 2,776 (6.3%) participants at baseline.

The median estimated exposure concentrations were $12.4{\mu g/m}^{3}$ $\left. \left\lbrack \text{interquartile}\,\text{range}\,\left( \text{IQR} \right) \right. = 4.4{\,\mu g/m}^{3} \right\rbrack$ for ${PM}_{2.5}$, $2.16{\mu g/m}^{3}$ ($5.8{\,\mu g/m}^{3}$) for ${PM}_{10}$, and $11.7\,\text{ppb}$ ($7.3\,\text{ppb}$) for $\text{NO}_{2}$. The results of the age-adjusted and fully adjusted regression analyses are presented in [Table 2](#t2){ref-type="table"}. No statistically significant associations were found between incident chronic bronchitis and any of the air pollution exposures. Limiting the incidence analysis to long-term residents ($> 10\; y$) did not appreciably alter the effect estimates (Table S1).

###### 

Odds ratios per interquartile range (IQR) increase in particulate matter ${PM}_{2.5}$ ($4.4\,{\mu g/m}^{3}$), $\text{NO}_{2}$ ($7.3\,\text{ppb}$), and ${PM}_{10}$ ($5.8\mspace{9mu}{\mu g/m}^{3}$).

Table 2 lists exposure and outcomes in the first and second columns, respectively. The odds ratio (95 percent confidence interval) and p values for age-adjusted and fully adjusted regression analyses are listed in the other columns.

  Exposure and outcome           Cases   Age adjusted        Fully adjusted                       
  ------------------------------ ------- ------------------- ---------------- ------------------- -------
  ${PM}_{2.5}$                                                                                     
   Incident chronic bronchitis   638     0.94 (0.84, 1.05)   0.256            0.94 (0.83, 1.06)   0.289
   Prevalent (at baseline)                                                                         
    Chronic bronchitis           1,351   1.04 (0.97, 1.13)   0.276            1.04 (0.96, 1.13)   0.318
    Chronic cough                3,749   1.03 (0.98, 1.08)   0.213            1.04 (0.99, 1.10)   0.103
    Chronic phlegm               2,776   1.07 (1.02, 1.13)   0.010            1.04 (0.98, 1.10)   0.213
    Chronic cough or phlegm      5,271   1.05 (1.01, 1.10)   0.015            1.04 (1.00, 1.09)   0.067
  $\text{NO}_{2}$                                                                                  
   Incident chronic bronchitis   638     0.95 (0.87, 1.03)   0.198            1.00 (0.92, 1.09)   0.974
   Prevalent (at baseline)                                                                         
    Chronic bronchitis           1,351   1.00 (0.95, 1.06)   0.923            1.05 (0.99, 1.11)   0.136
    Chronic cough                3,749   1.02 (0.99, 1.06)   0.215            1.06 (1.02, 1.10)   0.002
    Chronic phlegm               2,776   1.01 (0.97, 1.05)   0.730            1.02 (0.98, 1.07)   0.266
    Chronic cough or phlegm      5,271   1.02 (0.99, 1.05)   0.199            1.04 (1.01, 1.08)   0.008
  ${PM}_{10}$                                                                                      
   Incident chronic bronchitis   638     0.92 (0.85, 1.01)   0.066            0.98 (0.90, 1.08)   0.745
   Prevalent (at baseline)                                                                         
    Chronic bronchitis           1,351   1.06 (1.01, 1.12)   0.027            1.07 (1.01, 1.13)   0.019
    Chronic cough                3,749   1.04 (1.00, 1.07)   0.045            1.04 (1.00, 1.08)   0.030
    Chronic phlegm               2,776   1.07 (1.03, 1.12)   $< 0.001$        1.07 (1.02, 1.11)   0.002
    Chronic cough or phlegm      5,271   1.05 (1.01, 1.08)   0.001            1.05 (1.02, 1.08)   0.003

Note: Each outcome was compared to all participants without that outcome. The total number of participants with nonmissing data on all covariates was 38,006 for the analysis of incident outcomes, 44,158 for prevalent outcomes. Fully adjusted model includes age, race/ethnicity, body mass index, education, household income, occupational exposure to vapors/fumes or dust (ever), smoking status, total pack-years, and environmental tobacco smoke exposure. Primary outcome (incident chronic bronchitis) analysis additionally adjusted for length of follow-up time. CI, confidence interval; IQR, interquartile range; OR, odds ratio; PM, particulate matter.

For prevalent chronic bronchitis, a statistically significant positive association was seen with ${PM}_{10}$ \[odds ratio (OR) per IQR increase in ${PM}_{10} = 1.07$; 95% confidence interval (CI): 1.01, 1.13\] ([Table 2](#t2){ref-type="table"}). Similar magnitudes of association with prevalent chronic bronchitis were seen for $\text{NO}_{2}$ ($\text{OR} = 1.05$; 95% CI: 0.99, 1.11) and ${PM}_{2.5}$ ($\text{OR} = 1.04$; 95% CI: 0.96, 1.13), but were not statistically significant. ${PM}_{10}$ was also statistically significantly associated with chronic cough ($\text{OR} = 1.04$; 95% CI: 1.00, 1.08), chronic phlegm ($\text{OR} = 1.07$; 95% CI: 1.02, 1.11), and chronic cough or phlegm ($\text{OR} = 1.05$; 95% CI: 1.02, 1.08); coadjustment for ${PM}_{2.5}$ did not alter these effect estimates (Table S2). Adjustment of the ${PM}_{10}$ model for $\text{NO}_{2}$ resulted in a general attenuation of associations between prevalent symptoms and ${PM}_{10}$. This attenuation is likely due in part to the strong correlation between $\text{NO}_{2}$ and ${PM}_{10}$ (Pearson's *r*: 0.59).

$\text{NO}_{2}$ showed a significant positive association with chronic cough (OR = 1.06; 95% CI: 1.02, 1.10) and chronic cough or phlegm ($\text{OR} = 1.04$; 95% CI: 1.01, 1.08). In the $\text{NO}_{2}$ model, ORs were robust to coadjustment for ${PM}_{2.5}$ (Table S2). Coadjustment for ${PM}_{10}$ in the $\text{NO}_{2}$ model resulted in a loss of precision for the association between $\text{NO}_{2}$ and chronic cough or phlegm, and an overall decrease in size of effect estimates across all prevalent outcomes. The significant association with chronic cough was preserved ($\text{OR} = 1.05$; 95% CI: 1.01, 1.10). ORs for all pollutants and outcomes were generally very similar between age-adjusted and fully adjusted models.

For prevalent chronic bronchitis, sensitivity analyses incorporating additional case requirements into the classical symptom-based definition showed comparable effect estimates in association with ${PM}_{10}$ ([Table 3](#t3){ref-type="table"}). For example, ${PM}_{10}$ was significantly associated with prevalent chronic bronchitis defined either by symptoms or including participant-reported physician diagnosis (OR per IQR $\text{increase} = 1.06$; 95% CI: 1.02, 1.09). In an analysis of prevalent chronic bronchitis excluding baseline asthmatics, the effect estimate was similar but less precise, commensurate with the smaller sample size (OR for IQR increase in ${PM}_{10} = 1.06$; 95% CI: 0.99, 1.13). Similarly, exclusion of the 47% of participants who lived at their residence less than 10 y largely preserved the estimated association, but with loss of precision reflecting the smaller sample size (OR per IQR increase in ${PM}_{10} = 1.07$; 95% CI: 0.99, 1.16). Comparable sensitivity analyses involving ${PM}_{2.5}$ or $\text{NO}_{2}$ and prevalent chronic bronchitis yielded ORs that were similar in magnitude and direction to the primary models ([Table 3](#t3){ref-type="table"}). Effect estimates for all three pollutants were essentially unchanged by seasonal adjustment (Table S3).

###### 

Sensitivity analyses evaluating case definitions with additional inclusion or exclusion criteria for association of prevalent (baseline) chronic bronchitis with ambient air pollutants: odds ratios per interquartile range (IQR) increase in particulate matter ${PM}_{2.5}$ ($4.4\,{\,\mu g/m}^{3}$), $\text{NO}_{2}$ ($7.3\,\text{ppb}$), and ${PM}_{10}$ ($5.8\mspace{9mu}{\mu g/m}^{3}$).

Table 3 lists exposure and case definitions (primary and sensitivity analyses) in the first column; the corresponding N values, cases, adjusted odds ratio (95 percent confidence interval), and p values are listed in the other columns.

  Exposure and case definitions (primary and sensitivity analyses)   $n$[^*a*^](#t3n2){ref-type="table-fn"}   Cases   Adjusted OR (95% CI)   *p*-Value
  ------------------------------------------------------------------ ---------------------------------------- ------- ---------------------- -----------
  ${PM}_{2.5}$                                                                                                                                
   Prevalent chronic bronchitis (primary case definition)            44,158                                   1,351   1.04 (0.96, 1.13)      0.318
   Including physician diagnosis                                     44,099                                   4,698   1.04 (0.99, 1.09)      0.104
   Excluding asthma at baseline                                      41,488                                   1,104   0.99 (0.90, 1.08)      0.798
   Excluding those living at residence $< 10\; y$                    23,273                                   720     0.97 (0.87, 1.09)      0.643
  $\text{NO}_{2}$                                                                                                                             
   Prevalent chronic bronchitis (primary case definition)            44,158                                   1,351   1.05 (0.99, 1.11)      0.136
   Including physician diagnosis                                     44,099                                   4,698   1.02 (0.99, 1.06)      0.191
   Excluding asthma at baseline                                      41,488                                   1,104   1.02 (0.96, 1.09)      0.492
   Excluding those living at residence $< 10\; y$                    23,273                                   720     1.03 (0.95, 1.11)      0.444
  ${PM}_{10}$                                                                                                                                 
   Prevalent chronic bronchitis (primary case definition)            44,158                                   1,351   1.07 (1.01, 1.13)      0.019
   Including physician diagnosis                                     44,099                                   4,698   1.06 (1.02, 1.09)      0.001
   Excluding asthma at baseline                                      41,488                                   1,104   1.06 (0.99, 1.13)      0.077
   Excluding those living at residence $< 10\; y$                    23,273                                   720     1.07 (0.99, 1.16)      0.093

Note: For each case definition, the comparison group was all individuals without that outcome. Each analysis was performed independently for each case definition. Adjusted for age, race/ethnicity, body mass index, education, household income, occupational exposure to vapors/fumes or dust (ever), smoking status, total pack-years, and secondhand smoke exposure. CI, confidence interval; OR, odds ratio; PM, particulate matter.

^*a*^Total number of individuals with nonmissing data on all covariates for analysis.

In smoking-stratified analyses, we found evidence for stronger associations between all three air pollutants and prevalent outcomes in never-smokers ([Table 4](#t4){ref-type="table"}). ${PM}_{2.5}$ was strongly associated with prevalent chronic bronchitis among never-smokers (OR per IQR $\text{difference} = 1.18$; 95% CI: 1.04, 1.34), and the difference by smoking status was statistically significant ($p_{\text{interaction}} = 0.013$). Similarly with $\text{NO}_{2}$, in never-smokers, significant associations were seen for all four prevalent outcomes: chronic bronchitis ($\text{OR} = 1.10$; 95% CI: 1.01, 1.20), chronic cough ($\text{OR} = 1.10$; 95% CI: 1.05, 1.16), chronic phlegm ($\text{OR} = 1.07$; 95% CI: 1.01, 1.14), and chronic cough or phlegm ($\text{OR} = 1.09$; 95% CI: 1.04, 1.13), and the differences by smoking status were statistically significant for both cough ($p_{\text{interaction}} = 0.020$), phlegm ($p_{\text{interaction}} = 0.017$), and cough or phlegm ($p_{\text{interaction}} = 0.004$). Corresponding ORs for ${PM}_{2.5}$ and $\text{NO}_{2}$ were close to null for ever-smokers. For ${PM}_{10}$, results did not differ significantly by smoking status, although the same pattern of stronger associations in never-smokers was seen ([Table 4](#t4){ref-type="table"}).

###### 

Chronic bronchitis in relation to air pollutants \[particulate matter ${PM}_{2.5}$, $\text{NO}_{2}$, and ${PM}_{10}$\] by smoking status (never/ever): odds ratios per interquartile range (IQR) increase in ${PM}_{2.5}$ ($4.4\mspace{9mu}{\mu g/m}^{3}$), $\text{NO}_{2}$ ($7.3\,\text{ppb}$), and ${PM}_{10}$ ($5.8{\,\mu g/m}^{3}$).

Table 4 lists exposure and outcome in the first column; the corresponding number of cases, odds ratio (95 percent confidence interval), and p values for never-smoker and ever-smoker are listed in the other columns. The p interaction values are listed in the last column.

  Exposure and outcome           Never-smoker   Ever-smoker                                                         
  ------------------------------ -------------- ------------------- ----------- ------- ------------------- ------- -------
  ${PM}_{2.5}$                                                                                                       
   Incident chronic bronchitis   271            0.92 (0.77, 1.10)      0.382    367     0.95 (0.81, 1.11)   0.516   0.815
   Prevalent (at baseline)                                                                                           
    Chronic bronchitis           580            1.18 (1.04, 1.34)      0.011    771     0.96 (0.86, 1.07)   0.427   0.013
    Chronic cough                1,802          1.07 (1.00, 1.15)      0.053    1,947   1.02 (0.95, 1.10)   0.545   0.345
    Chronic phlegm               1,362          1.08 (1.00, 1.17)      0.059    1,414   1.00 (0.92, 1.09)   0.956   0.189
    Chronic cough or phlegm      2,632          1.06 (0.99, 1.12)      0.077    2,639   1.03 (0.97, 1.10)   0.292   0.638
  $\text{NO}_{2}$                                                                                                    
   Incident chronic bronchitis   271            1.03 (0.91, 1.17)      0.609    367     0.97 (0.86, 1.10)   0.660   0.498
   Prevalent (at baseline)                                                                                           
    Chronic bronchitis           580            1.10 (1.01, 1.20)      0.029    771     1.00 (0.92, 1.08)   0.955   0.097
    Chronic cough                1,802          1.10 (1.05, 1.16)    $< 0.001$  1,947   1.01 (0.96, 1.06)   0.642   0.020
    Chronic phlegm               1,362          1.07 (1.01, 1.14)      0.014    1,414   0.97 (0.92, 1.03)   0.359   0.017
    Chronic cough or phlegm      2,632          1.09 (1.04, 1.13)    $< 0.001$  2,639   0.99 (0.95, 1.04)   0.806   0.004
  ${PM}_{10}$                                                                                                        
   Incident chronic bronchitis   271            1.04 (0.91, 1.18)      0.587    367     0.95 (0.83, 1.08)   0.458   0.359
   Prevalent (at baseline)                                                                                           
    Chronic bronchitis           580            1.09 (1.00, 1.20)      0.055    771     1.06 (0.98, 1.14)   0.131   0.597
    Chronic cough                1,802          1.07 (1.01, 1.12)      0.015    1,947   1.02 (0.97, 1.08)   0.391   0.260
    Chronic phlegm               1,362          1.10 (1.04, 1.17)      0.002    1,414   1.04 (0.98, 1.10)   0.179   0.189
    Chronic cough or phlegm      2,632          1.08 (1.03, 1.13)    $< 0.001$  2,639   1.02 (0.98, 1.07)   0.352   0.081

Note: For each case definition, the comparison group was all individuals without that outcome. The total number of participants with nonmissing data on all covariates was 38,006 (21,527 never-smokers and 16,479 ever-smokers) for the analysis of incident outcomes and 44,158 (24,894 never-smokers and 19,264 ever-smokers) for prevalent outcomes. Adjusted for age, race/ethnicity, body mass index, education, household income, occupational exposure to vapors/fumes or dust (ever), total pack-years, and environmental tobacco smoke exposure. Incident analysis additionally adjusted for length of follow-up time. CI, confidence interval; IQR, interquartile range; OR, odds ratio; PM, particulate matter.

Discussion {#s4}
==========

To our knowledge, this is the largest study to investigate the association between classically defined chronic bronchitis and long-term ambient air pollution exposure using a validated national exposure model. We did not find an association between incident chronic bronchitis and any of the three air pollution measures. However, exposure to higher concentrations of ${PM}_{10}$ was significantly associated with all prevalent outcomes: chronic bronchitis, chronic cough, chronic phlegm, and chronic cough or phlegm. These findings were robust to coadjustment for ${PM}_{2.5}$ in a two-pollutant model (Table S2). We also found $\text{NO}_{2}$ exposure was significantly associated with chronic cough and chronic cough or phlegm. To the best of our knowledge, no other study has shown an association between ${PM}_{10}$ and classically defined chronic bronchitis. These findings provide evidence that long-term ambient air pollution exposure, particularly ${PM}_{10}$, is a risk factor for chronic bronchitis and the chronic respiratory symptoms of cough and phlegm that define it.

Incident chronic bronchitis should be superior to prevalent chronic bronchitis for making causal inference regarding observed associations with air pollution. However, the relatively short follow-up duration (mean: 5.7 y) limited our power to detect an association between ambient air pollutants and incident chronic bronchitis. With the much larger number of cases of prevalent conditions, we had substantially higher power than for the incident analyses. One smaller study of nonsmoking Seventh Day Adventists in California has shown an association between incident chronic bronchitis and long-term exposure to ${PM}_{2.5}$; however, levels were in excess of $20{\,\mu g/m}^{3}$, a concentration almost double that observed in our study ([@c1]).

Comparison to previous studies is limited due to substantial variability in defining chronic bronchitis and exposure estimation methods. The observed incidence rate of 2.5 cases per 1,000 person-years and prevalence of 2.9% are at the low end of the range reported in the literature ([@c5]; [@c8]; [@c12]; [@c16]; [@c29]). However, our study population was more than half nonsmoking women, and our estimates are in agreement with study populations with similar demographics ([@c21]; [@c30]). National prevalence and incidence figures for chronic bronchitis are lacking because they rely on physician diagnosis rather than the classical symptom-based diagnostic criteria ([@c2]). Including participant-reported physician diagnosis greatly increases the prevalence of chronic bronchitis in this study and likely elsewhere ([@c27]).

Our study provides evidence that ${PM}_{10}$ exposure is a risk factor for chronic bronchitis, while the existing literature suggests associations between ${PM}_{10}$ and various respiratory symptoms. A large cross-sectional study in Switzerland found an association between increased prevalence of chronic cough and phlegm with ${PM}_{10}$ exposure among never-smokers ([@c34]). The European Study of Cohorts for Air Pollution Effects (ESCAPE) meta-analysis of five European cohorts similarly showed an association between ${PM}_{10}$ and prevalent chronic phlegm, but not chronic bronchitis, in never-smokers ([@c5]). A French study of elderly adults demonstrated increased prevalence of chronic cough associated with ${PM}_{10}$ exposure ([@c3]a). Furthermore, in the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA) cohort, decline in ${PM}_{10}$ over time was associated with a reduction in chronic cough and phlegm ([@c28]). Our study suggests long-term ${PM}_{10}$ exposure is associated with prevalent chronic bronchitis, the distinct clinical entity, as well as the associated symptoms that define it.

In contrast to ${PM}_{2.5}$, which deposits within the distal alveoli, the preferential deposition of coarse particles within the conducting airways of the tracheobronchial tree provides biologic plausibility for the association between ${PM}_{10}$ and chronic bronchitis ([@c6]). Chronic airway epithelial inflammation and mucus metaplasia are the pathologic bases of chronic bronchitis ([@c15]). Chronic bronchitis is associated with narrowing and mucus plugging of the nonalveolated conducting airways ([@c20]). PM has been frequently implicated in triggering pro-inflammatory cascades within airway epithelial cells ([@c22]). Certain ${PM}_{10}$ components, including transition metals and endotoxins, have been shown to drive airway inflammation and mucus hypersecretion via upregulation of transcription factors and generation of reactive oxygen species and oxidative stress ([@c18]; [@c22]).

For $\text{NO}_{2}$, we saw no associations with prevalent chronic bronchitis or chronic phlegm in the main analyses; however, there were positive associations with both chronic cough and chronic cough or phlegm. These associations were robust to coadjustment for ${PM}_{2.5}$. Adjustment for ${PM}_{10}$, in an attempt to isolate the effect of $\text{NO}_{2}$, was limited by the strong correlation between these copollutants. Previous studies have shown inconsistent associations between respiratory symptoms and $\text{NO}_{2}$. The ESCAPE meta-analysis showed no significant association between $\text{NO}_{2}$ and chronic bronchitis, cough, or phlegm ([@c5]). The German Study on the Influence of Air Pollution on Lung, Inflammation and Aging (SALIA) cohort analysis showed association with cough, but not chronic bronchitis, while the Swiss SAPALDIA study showed no association overall ([@c27]; [@c34]). In both the SALIA and SAPALDIA studies, conducted in the 1990s, the annual mean $\text{NO}_{2}$ levels were more than double those in our study.

Among never-smokers, associations between prevalent symptoms and exposures were stronger for all pollutants. If we limit our interpretation of the stratified analyses to those with statistically significant interactions, we find stronger evidence for associations between both $\text{NO}_{2}$ and ${PM}_{2.5}$ and our prevalent outcomes among never-smokers. The finding of stronger associations with these two pollutants and outcomes in never-smokers is consistent with some previous literature findings. In the Swiss SAPALDIA study, $\text{NO}_{2}$ was related to chronic bronchitis only among nonsmokers. For ${PM}_{2.5}$, the ESCAPE meta-analysis found a positive association between chronic cough and ${PM}_{2.5}$ only among never-smokers ([@c5]). $\text{NO}_{2}$ was associated with chronic cough in a study of about 4,700 women in Germany, 74% of whom were never-smokers ([@c27]).

The reason for stronger associations with $\text{NO}_{2}$ in never-smokers in our study and others is unclear. Perhaps the airways of smokers are more tolerant to the irritant effects of ambient $\text{NO}_{2}$ than nonsmokers who, as a result, are dissuaded from smoking because of greater sensitivity to these effects. Alternatively, the effects of compounds in cigarette smoke might swamp the effects of ambient $\text{NO}_{2}$ exposure. Stronger associations with ${PM}_{2.5}$ in never-smokers could reflect, in part, the high dose of fine particles inhaled by smokers. The biologic effects of cigarette smoke may overwhelm the effects from long-term, low-level ambient air pollution and thus mask any association. For ${PM}_{10}$, we saw clear associations with chronic bronchitis in all subjects, possibly related to ${PM}_{10}$ favoring deposition in the conducting airways that are responsible for producing bronchitic symptoms. This association is apparent in the aggregate sample. In contrast, the associations between chronic bronchitis and ${PM}_{2.5}$ and $\text{NO}_{2}$ were only apparent in never-smokers. Theses pollutants have distribution patterns that tend to bypass the conducting airways for deposition and adsorption in the distal alveoli.

Outcome misclassification was reduced by using the symptom-defined definition of chronic bronchitis. However, the symptom-based questionnaire still has limitations; due to recall bias, it likely results in inclusion of cases with recent, but not necessarily chronic, symptoms. Overlap with asthma remains possible given the clinical similarities of these conditions. Sensitivity analyses excluding subjects with a physician diagnosis of asthma and active asthma symptoms at baseline attenuated the association with all pollutants. However, the exclusion of these participants with overlapping chronic bronchitis symptoms may have eliminated true cases of chronic bronchitis and thus reduced power.

The sensitivity analysis including individuals reporting doctor diagnosis of chronic bronchitis showed preserved associations with increased precision. Self-report of doctor diagnosis is likely to include more individuals with symptom duration shorter than the 2-y minimum required for the chronic bronchitis definition (i.e., may include participants who have received a diagnosis of acute bronchitis in the past). Given that chronic bronchitis is defined by duration of symptoms, directly asking subjects questions on cough and phlegm is preferable to asking about physician diagnosis, which requires accurate reporting by both parties. However, the association between ${PM}_{10}$ and prevalent chronic bronchitis remains robust, even with the less strict definition, suggesting that presence of symptoms is driving the relationship, rather than the specific duration of symptoms.

The objection has been raised that chronic bronchitis prevalence as reported on questionnaires may reflect recent symptoms and that prevalence and/or severity might then vary by season. Therefore, we undertook a sensitivity analysis adjusting for season of both baseline and follow-up questionnaire (Table S3). No change was observed in the effect estimates for outcomes associated with ${PM}_{2.5}$ or $\text{NO}_{2}$. The associations between prevalent chronic bronchitis and chronic cough and ${PM}_{10}$ were no longer statistically significant after adjusting for season, but the effect estimates remained largely unchanged and in the anticipated direction. Season of questionnaire administration does not seem to contribute significant bias in reporting of chronic bronchitis.

Our air pollution exposure estimates are based on a validated national model using land-use regression and spatial smoothing to capture within- and between-region air pollution variability and minimize exposure misclassification. This model is a considerable improvement over road proximity, regional fixed-monitor averages, and simple land-use regression models employed in prior chronic bronchitis investigations ([@c13]; [@c33]). In addition, seasonal bias in the exposure should be mitigated by using annual averages and a chronic outcome whose case definition dictates that symptoms must span a minimum of 2 consecutive years. Air pollution estimates used year 2000 annual averages, predating baseline enrollment for all participants. While concentrations of criteria pollutants are declining nationally, spatial differences of annual average pollution concentrations account for the majority of variability in ${PM}_{2.5}$ measurement and were relatively stable across the study period ([@c14]). However, it is acknowledged that variability in the decline in pollution levels may contribute to exposure misclassification, and the resulting biases are difficult to predict. It is plausible that our observed lack of association for incident outcomes and positive effects for prevalent symptoms could be related to variable change in pollution levels; e.g., if the most polluted regions experienced more dramatic declines in levels than the cleaner areas.

Additional limitations exist. This study is limited to women, and the findings may not be broadly applicable to men. Outdoor ambient pollutant concentrations may not reflect the indoor exposures. Exposure measurement error owing to our use of residential addresses to characterize exposure owing both to subjects' residential mobility, time spent away from home or indoors, and spatiotemporal trends is a limitation both of this study and epidemiological studies of air pollution health effects in general. Exposure measurement of this nature error is generally expected to bias associations toward the null rather than producing false positive associations.

In 2006, the EPA revoked the National Ambient Air Quality Standard for annual ${PM}_{10}$ due to insufficient data on health risks associated with long-term exposure to ${PM}_{10}$ as opposed to the finer ${PM}_{2.5}$ fraction ([@c32]). The preceding long-term ${PM}_{10}$ exposure standard was an annual average of $50\,{\mu g/m}^{3}$, roughly double the mean concentration experienced by participants in this study. This study provides evidence that chronic respiratory health effects occur with long-term exposure to ${PM}_{10}$ at levels below the previous national standards. These results add to a limited body of evidence relating morbidity to long-term ${PM}_{10}$ exposure and consequently may have policy implications both nationally and globally.
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